A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice

2001 ◽  
Vol 37 (1) ◽  
pp. 106-113 ◽  
Author(s):  
J. Lee ◽  
M. Weber ◽  
S. Mejia ◽  
E. Bone ◽  
P. Watson ◽  
...  
Bone ◽  
2004 ◽  
Vol 34 (4) ◽  
pp. 697-709 ◽  
Author(s):  
Nadia Rucci ◽  
Enrico Ricevuto ◽  
Corrado Ficorella ◽  
Maurizio Longo ◽  
Marie Perez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document